Biotech Values

[DewDiligence]

>>When DNDN announced the progression miss and the interim 9902A survival data in January, they asked ASCO to pull the presentation. ASCO did, but apparently failed to inform their webmaster. Within one day or so of seeing it show up on the website, it was pulled from the website. Apparently, after January, it never was on the official agenda.<<

Why didn’t anyone correct the posts by ‘radiationcancerdoc’ and others from two weeks ago that touted the ASCO presentation?

If it was not widely known that the presentation had been pulled several months ago, some traders may have thought this was fresh dirt. If so, this could be an explanation, at least in part, for the immense weakness in the stock recently.